Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Jacobsen

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Scientific Reports|May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
BMC Cancer|January 7, 2018
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancerAsmus Heumann, Nina Heinemann, Claudia Hube-Magg, et al.
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Scientific Reports|May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
BMC Cancer|January 7, 2018
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancerAsmus Heumann, Nina Heinemann, Claudia Hube-Magg, et al.
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Pageof 19